D

Hims & Hers Health, Inc. HIMS

$27.51 $0.070.26% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Hims & Hers Health, Inc. is a U.S.-based telehealth and wellness company that operates primarily through a direct-to-consumer digital healthcare platform. The company provides online access to licensed healthcare professionals, prescription and non-prescription treatments, and wellness products across several healthcare categories, including mental health, dermatology, sexual health, primary care, weight management, and hair loss. The company operates within the broader digital health, telemedicine, consumer healthcare, and pharmaceutical fulfillment industries.

The company’s primary revenue drivers include subscription-based healthcare services, recurring prescription fulfillment, and sales of branded wellness products through its online platform. Its customer base consists largely of consumers seeking convenient, digitally enabled healthcare access without traditional in-person visits. A significant strategic differentiator is the integration of telehealth consultations, pharmacy fulfillment, and consumer branding into a single platform. Founded in 2017 by Andrew Dudum and Jack Abraham, the company initially focused on men’s wellness under the “Hims” brand before expanding into women’s healthcare through “Hers.” The company later broadened into chronic care, mental health, and preventative health services, reflecting a wider consumer healthcare strategy.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
415 851 0195
Address
2269 Chestnut Street
Suite 523
San Francisco, CA 94123
Country
Year Founded

Headlines